Taken together, these findings suggest that activation of eIF-2α signaling pathway is an underlying mechanism for the development of atherosclerosis in apoE−/− mice and that inhibition of this UPR pathway might provide a therapy strategy for treatment of atherosclerosis. This evidence concerns the gene EIF2A and atherosclerosis.